当前位置：
X-MOL 学术
›
Melanoma Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon α-2b.
Melanoma Research ( IF 1.5 ) Pub Date : 2021-09-13 , DOI: 10.1097/cmr.0000000000000769 Shijie Lan , Zhihua Cui , Qiliang Yin , Zhigang Liu , Lingling Liang , Hua He , Hesong Liu , Zhen Guo , Yingying Yu , Di Wu
Melanoma Research ( IF 1.5 ) Pub Date : 2021-09-13 , DOI: 10.1097/cmr.0000000000000769 Shijie Lan , Zhihua Cui , Qiliang Yin , Zhigang Liu , Lingling Liang , Hua He , Hesong Liu , Zhen Guo , Yingying Yu , Di Wu
Retinopathy is a rare side effect of interferon α-2b treatment. The goal of this study was to prospectively investigate the clinical characteristics of Chinese patients with melanomas who developed retinopathy following high doses of interferon α-2b (HD-IFN) therapy. The study included 56 melanoma stage I-III patients that were treated with HD-IFN. Fourty-three patients developed HD-IFN-induced retinopathies. Forty-three melanoma patients (76%) developed retinopathy after being treated with HD-IFN. Among these patients, 49% had cotton-wool spots, 19% had retinal hemorrhage, and 30% had retinal hemorrhage. The median time of occurrence of retinopathy was 4 weeks after treatment, and the median time of duration was 4 weeks. No patient showed other symptoms except one who had blurred vision. A comparison of clinical characteristics (age, gender, primary site, stage, and ulceration) and laboratory examinations (white blood cell and platelet counts, hemoglobin, serum lactate dehydrogenase, alanine transaminase, aspartate aminotransferase, triiodothyronine, thyroxine, thyroid-stimulating hormone, and lipid) between the HD-IFN-induced retinopathy patients and nonretinopathy patients did not show any significant differences (P > 0.05). Although all patients that developed retinopathy had diabetes or hypertension, an equal percentage of patients were without retinopathy had diabetes or hypertension. HD-IFN therapy in patients with melanomas may induce mild retinopathy. Our results; however, do not necessarily suggest to discontinue the HD-IFN treatment because retinopathy is a reversible disorder.
更新日期：2021-09-13
京公网安备 11010802027423号